The advance of bioactive peptide RGD in the research of bone regeneration.
- Author:
Kai QIU
1
;
Xin CHEN
;
Tianquan LI
;
Changxiu WAN
Author Information
1. Department of Polymer Materials and Engineering, Sichuan University, Chengdu 610065.
- Publication Type:Journal Article
- MeSH:
Biocompatible Materials;
Bone Regeneration;
drug effects;
physiology;
Cell Adhesion;
drug effects;
Oligopeptides;
administration & dosage;
chemistry;
pharmacology;
Osteoblasts;
drug effects;
physiology;
Osteoclasts;
drug effects;
physiology;
Tissue Engineering;
methods
- From:
Journal of Biomedical Engineering
2003;20(3):546-549
- CountryChina
- Language:Chinese
-
Abstract:
Clinically, there has been so far no effective way to repair the bone-missing of large extent due to gash, infection and removal of tumor. The solution of this problem can be assisted by the addition of bioactive substances to substrate materials, because the growth of peripheral tissue and the fiber tissue growing the materials can be induced to the direction of bone-tissue by these biomaterials with bioactive peptides. The peptide Arg-Gly-Asp is the point between the integrin which comes from membrane and the ligand. In certain cases, the artificially synthesized RGD can be competitively combined with the integrin on cell surface, and outer-cell information is transmitted into cells, which will cause a series of physiological changes in cells. Presently, it is reported that the RGD has the ability to induce the growth of osteoblasts, restrain the adhesion between osteoclasts and substrates. This paper reviews and introduces the progress made with the work of RGD-inducing bone regeneration.
